Adenoviridae Infections - 138 Studies Found Recruiting : A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade : Advanced or Unresectable Melanoma Progressing After PD1 Blockade : 2016-12-19 : Biological: ONCOS-102 Engineer Completed : A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers : Ovarian Cancer : 2009-06-11 : Genetic: Ad5.SSTR/TK.RGD Group Completed : Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults : Healthy Adult Immune Responses to Vaccine : 2014-09-03 : Biological: VRC-EBOADC069-00-VP Recruiting : Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer : Pancreatic Cancer : 2016-08-10 : Biological: Theragene®,Ad5-yCD/mutTKSR39rep-ADP Theragene®,Ad5-yCD/mutTKSR39rep-ADP is Adenovi Active, not recruiting : NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1 : Plasmodium Falciparum : 2006-10-24 : Biological: NMRC-M3V-Ad-PfCA M Recruiting : Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation : CMV Infection EBV Adenovirus< : 2016-05-18 : Biological: Virus specific CTLs Virus specific CTLs will be given to patients with persistent or recurre Recruiting : Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) : EBV CMV Adenovirus : 2013-09-12 : Drug: CTL for CMV seropositive donors Active, not recruiting : Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor : Advanced Solid Tumor : 2005-12-02 : Drug: Antangiogenesis Genetic: endostatin Terminated : Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence : End Stage Renal Disease : 2009-05-07 : Procedure: Graft placement surgery plus Trinam therapy Tri Active, not recruiting : Intranasal AD4-H5-VTN as an Adenovirus Vaccine : Healthy Volunteer : 2013-03-06 : Biological: Ad4-H5-Vtn <<< Previous | Next >>>
